InnoCare Pharma Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 1,146 full-time employees. The company went IPO on 2020-03-23. InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The firm focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The firm's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The firm is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The firm conducts its businesses in domestic and overseas markets.
09969.HK stock price ended at $12.58 on 월요일, after dropping 2.78%
On the latest trading day Jan 19, 2026, the stock price of 09969.HK fell by 2.78%, dropping from $12.94 to $12.58. During the session, the stock saw a volatility of 3.94%, with prices oscillating between a daily low of $12.45 and a high of $12.94. On the latest trading day, the trading volume for 09969.HK decreased by 574.0K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.5M shares were traded, with a market value of approximately $18.7B.
09969.HK 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 2
매도 신호 3
Strong Sell
Sell
Neutral
Buy
Strong Buy
09969.HK은 현재 2개의 매수 신호와 3개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 하락 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 -5.13%입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
09969.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 09969.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.